Palbociclib-fulvestrant (PALBO-FUL) and everolimus-exemestane (EVE-EXE) for second line hormonal treatment (HT) of metastatic breast cancer (MBC) with lobular histology: A propensity score matched analysisArmando Orlandi,Elena Iattoni,Laura Pizzuti,Agnese Fabbri,Andrea Botticelli,Carmela Di Dio,Antonella Palazzo,Giovanna Garufi,Giulia Indellicati,Daniele Alesini,Luisa Carbognin,Ida Paris,Angela Vaccaro,Luca Moscetti,Alessandra Cassano,Patrizia Vici,Valentina Magri,Giuseppe Naso,Diana Giannarelli,Paolo Marchetti,Emilio Bria,Giampaolo TortoraCANCER RESEARCH(2020)引用 2|浏览66暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要